search

Active clinical trials for "Migraine Disorders"

Results 221-230 of 1206

A Study to Evaluate White Matter Hyperintensities in Migraine

MigraineSmall Vessel Ischemic Disease1 more

The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines

Active27 enrollment criteria

Examination of Muscle Stiffness, Tenderness and Pressure Pain Thresholds During a Cycle of Botulinum...

Chronic Migraine

Preventive treatment with botulinum toxin A injections is standard care for chronic migraine and follows the PREEMPT protocol. Patients are injected at 31 locations in the frontal, corrugator and procerus muscle, the temporalis muscle, the occipitalis muscle, the cervical paraspinal muscle group and the trapezius muscles (11). The treatment is repeated every 12 weeks, performed by specially trained medical doctors or nurses. We will measure elastography of the trapezius muscle before and 5-6 weeks after botox injection. In addition measure with QST

Recruiting6 enrollment criteria

Cervical Repositioning Error in Chronic Migraine

MigraineChronic Migraine

This study examines cervical joint position sense in individuals with chronic migraine vs. healthy controls. The ability to reposition the cervical spine after active movement will be evaluated in different head positions. Impaired proprioception and motor control is hypothesized in the migraine group.

Recruiting6 enrollment criteria

Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant...

Migraine

The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.

Recruiting3 enrollment criteria

Cross-cultural Adaptation, Reliability and Validity of the Turkish Version of the Headache Disability...

HeadacheHeadache Disorders6 more

The purpose of this study was to investigate cultural adaptation, reliability and validity of the Turkish version of the Headache Disability Questionnaire (HDQ).

Recruiting3 enrollment criteria

Validating a Modified COMPASS 31questionnaire for Treatment Outcomes

HeadacheMigraine2 more

Eligible participants will complete the COMPASS 31 (year), modified COMPASS 31(one month) and the NSI (one month) questionnaires at baseline and complete the modified COMPASS 31 and the NSI after usual care of treatment. The investigators will Compare results for the COMPASS 31(year) to the modified COMPASS 31(month) at baseline. Compare modified COMPASS 31(month) to the NSI at baseline and post intervention.

Recruiting2 enrollment criteria

Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy...

Migraine

Migraine is a common neurological disorder typically characterized by attacks of throbbing or pulsating headache on one side of the head of moderate to severe pain intensity. The purpose of this study is to evaluate fetal, maternal, and infant outcomes through 12 months of age among women exposed to Ubrelvy during pregnancy, as well as in 2 Ubrelvy-unexposed comparison groups. Ubrelvy (ubrogepant) is an approved drug for the acute treatment of migraine in adults. Approximately 560 pregnant women with migraine exposed to Ubrelvy and 560 pregnant women with migraine without exposure to Ubrelvy will be enrolled in this study in the United States. Participants enrolled in the Ubrelvy-exposed group will receive Ubrelvy as prescribed by their physician. There may be higher treatment burden for participants in this trial compared to their standard of care.

Recruiting10 enrollment criteria

Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy

Migraine

The purpose of the study is to evaluate the risk of pregnancy and infant outcomes among women with migraine exposed to rimegepant during pregnancy and in two rimegepant unexposed comparator groups.

Recruiting23 enrollment criteria

Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine

Migraine

The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.

Active19 enrollment criteria

Longitudinal Study of the Patients With Medication-overuse Headache or Migraine That Completed Baseline...

Migraine DisordersMedication-overuse Headache

This is a phone interview research study for patients with migraine or medication-overuse headache (MOH) who have completed baseline MRI scans. Participants will be interviewed by phone at 3, 12, 24 months after the baseline MRI scans. The purpose of this study is to potentially identify the baseline brain functional or structural signatures (functional connectivity, regional homogeneity, amplitude of low frequency fluctuation, and so such) that are predictive of the short- and long- term outcomes as well as treatment response of migraine and MOH patients.

Recruiting3 enrollment criteria
1...222324...121

Need Help? Contact our team!


We'll reach out to this number within 24 hrs